Brief: Scpharmaceuticals Announces FDA Approval Of Furoscix® (Furosemide Injection) For The At-Home Treatment Of Congestion In Chronic Heart Failure
10/10/2022 13:07
Oct 10 (Reuters) - ScPharmaceuticals Inc SCPH.O :
* SCPHARMACEUTICALS ANNOUNCES FDA APPROVAL OF FUROSCIX®
(FUROSEMIDE INJECTION), THE FIRST AND ONLY SELF-ADMINISTERED,
SUBCUTANEOUS LOOP DIURETIC FOR THE AT-HOME TREATMENT OF
CONGESTION IN CHRONIC HEART FAILURE
Source text for Eikon: ID:nGNX6rJqnx
Further company coverage: SCPH.O
((Reuters.Briefs@thomsonreuters.com;))